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Abstract
O-linked b-N-acetlyglucosamine or O-GlcNAc modification is a dynamic post-translational modification occurring on the Ser/Thr residues of
many intracellular proteins. The chronic imbalance between phosphorylation and O-GlcNAc on tau protein is considered as one of the main hall-
marks of Alzheimer’s disease. In recent years, many studies also showed that O-GlcNAc levels can elevate upon acute stress and suggested that
this might facilitate cell survival. However, many consider chronic stress, including oxidative damage as a major risk factor in the development
of the disease. In this study, using the neuronal cell line SH-SY5Y we investigated the dynamic nature of O-GlcNAc after treatment with 0.5 mM
H2O2 for 30 min. to induce oxidative stress. We found that overall O-GlcNAc quickly increased and reached peak level at around 2 hrs post-
stress, then returned to baseline levels after about 24 hrs. Interestingly, we also found that tau protein phosphorylation at site S262 showed
parallel, whereas at S199 and PHF1 sites showed inverse dynamic to O-Glycosylation. In conclusion, our results show that temporary elevation
in O-GlcNAc modification after H2O2-induced oxidative stress is detectable in cells of neuronal origin. Furthermore, oxidative stress changes the
dynamic balance between O-GlcNAc and phosphorylation on tau proteins.
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Introduction
Cells maintain their intracellular milieu within a quite narrow range.
This is a dynamic equilibrium which stabilizes the cells’ internal envi-
ronment in response to the alterations of external conditions. Cells
exposed to any damage react with a complex mechanism called
stress response which varies by the actual tolerance level of the given
cell type and the duration and severity of the stress [1]. When the
impairment of the cells does not cause immediate cell death (necro-
sis), the cells may recover and adapt to the changed environment [2].
When complete adaptation is not possible, stress response will
include hypertrophy, hyperplasia, atrophy and metaplasia or activa-
tion of death signalling pathways: apoptosis, necrosis or autophagy
cell death [1, 3, 4]. Not surprisingly, dysfunctions of the adaptive
mechanisms play an important role in many diseases such as ischae-
mia, diabetes, atherosclerosis, neurodegenerative disorders and
tumours.
Stress response induces and regulates a variety of intracellular
adaptive mechanisms ranging from receptor binding, signal transduc-
tion, gene transcription to protein synthesis [5]. These mechanisms
contribute to the survivability of the cells by controlling cell cycle,
repairing/stabilizing functional proteins, removing of damaged mole-
cules, mobilizing stored resources and modifying metabolic pathways
[3, 6, 7]. Cellular proteins are regulated in these processes at multiple
levels; altered protein degradation (e.g. activation of caspases) or
synthesis (transcriptional changes, unfolded protein response) and
functional changes [8–10]. Post-translational modifications such as
phosphorylation, glycosylation and acetylation also play a critical role
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in these processes, as they can reversibly or irreversibly modify the
structure, the stability and the function of proteins [11].
Recently, several studies indicated the involvement of a special
post-translational modification in stress response: O-linked b-N-
acetylglucosamine or O-GlcNAc modification [12, 13]. Upon
O-GlcNAc modification, a single N-acetylglucosamine is attached to
the hydroxyl group of serine or threonine moieties of cytosolic and
nuclear proteins [14]. This modification is a dynamic and reversible
process and was shown to impact so far more than 1000 cytoplas-
mic, nuclear and mitochondrial proteins such as NF-Κb, PI3-kinase,
endothelial nitric oxide synthase, O-GlcNAc transferase (OGT),
a-tubulin, c-myc and heat shock protein 70 [15, 16]. It plays a
critical role in the regulation of signal transduction, transcriptional
activity, cell-cycle regulation, protein degradation and glucose
metabolism [15]. Previous studies have shown that increased
O-GlcNAc has a protective role in acute stress, best characterized
in cardiac cells [17]. Recent findings suggest that O-GlcNAc is also
abundant in neuronal tissues [18] and it was shown that chronic
imbalance between O-GlcNAc and phosphorylation on tau proteins
is a major element in the pathophysiology of Alzheimer’s disease
[19]. Although it was shown that O-GlcNAc is dynamic and is
induced by excitatory neuronal stimuli [18], the regulation of
O-GlcNAc during acute stress in neuronal cells is far from com-
pletely understood.
The aim of this study was to investigate the dynamic change in
O-GlcNAc in the neuronal cell line SH-SY5Y after H2O2-induced oxida-
tive stress. We found that intracellular O-GlcNAc rapidly elevated after
treatment with 0.5 mM H2O2 for 30 min., reached peak level then
declined close to the basal level. Moreover, reciprocal relationship
between O-GlcNAc and phosphorylation of tau protein after oxidative
stress was directly demonstrated. These findings suggest that the
pathophysiology of neurodegenerative diseases might be connected
to cellular stress adaptation mechanisms.
Materials and methods
Cell line and culture conditions
SH-SY5Y neuroblastoma cells (ATCC CRL-2266 human neuroblastoma)
were grown in a 1:1 mixture of EMEM and Ham’s F12 medium supple-
mented with 10% foetal bovine serum (FBS), 1% non-essential amino
acids, penicillin (100 U/ml) and streptomycin (100 lg/ml). The cells
were incubated at 37°C, in 95% air–5% CO2 atmosphere in a humidified
incubator. Subculturing was performed in every 2–3 days and fresh
medium was replaced 12–24 hrs prior to each experiment. The experi-
ments were performed on the cells at 80% or less confluency. Oxidative
conditions were chosen based on experimental set-ups found in the lit-
erature [20, 21] and our pilot experiments (data not shown). Our aim
was to decrease the viability to ~75% by the treatment. Thus, cells were
treated with 0.5 mM H2O2 for 30 min. in serum-free medium to avoid
rapid H2O2 degradation by antioxidants present in FBS. After the treat-
ment, the medium was replaced by complete medium and the cells
were incubated as described above for the following recovery times: 0,
30, 60 min. and 2, 4, 24, 48 and 72 hrs.
Western blot analysis
The treated cells were washed twice in ice-cold PBS buffer and har-
vested in RIPA buffer [10 mM Tris pH 7.2, 100 mM NaCl, 1 mM
ethylenediaminetetraacetic acid (EDTA), 1 mM ethylene glycol-bis
(2-aminoethylether)-N,N,N’,N’-tetraacetic acid (EGTA), 0.1% SDS, 1%
Triton-X 100, 0.5% deoxycholate, 10% glycerol, protease inhibitor cock-
tail: 1 tablet/10 ml (Roche Applied Science, Penzberg, Germany)], kept
on ice for 30 min. and centrifuged for 10 min. at 4°C at 14,000 9 g.
From the supernatant the total protein concentration was determined
using Bio-Rad Dc Assay Kit. Proteins were separated on 7.5% SDS-
PAGE and transferred onto polyvinylidene difluoride membranes (Milli-
pore, Billerica, MA, USA). The same amount of protein of each sample
was confirmed by SYPRO Ruby Protein Blot Stain (Bio-Rad, Hercules,
CA, USA) on the membranes. Blots were probed with the anti-O-GlcNAc
antibody CTD110.6 (monoclonal mouse IgM, 1:2000; Sigma-Aldrich, St.
Louis, MO, USA) in 1% casein blocking buffer and followed with HRP
conjugated goat antimouse IgM (1:5000; Thermo Fisher Scientific, Wal-
tham, MA, USA). Blots were also probed with mouse (monoclonal) anti-
tau antibody (1:250) and rabbit (polyclonal) anti-tau [Ps199] phophos-
pecific antibody (1:1000; Thermo Fisher Scientific), rabbit (polyclonal)
anti-tau [Ps262] antibody (1:1000; Abcam, Cambridge, MA, USA) and
PHF1 (anti-tau Ps396/404) (1:200; gift from Dr. P. Davies, Albert Einstein
College of Medicine, Bronx, NY, USA) according to the manufacturer’s
protocol. The blots were developed using Femto chemiluminescent sub-
strate (Thermo Fisher Scientific) and the signal was visualized by Kodak
Image Station 2000R. Kodak 1D and ImageJ analysis software were
used to quantify the intensity of bands.
Cell viability test
Cells were lifted by trypsin and quickly washed 29 in ice-cold PBS.
Approximately 106 cells/sample were stained with Propidium Iodide and
Annexin V-FITC according to the manufacturer’s instruction (BD
Pharmingen, Heidelberg, Germany). The fluorescence signal of Propid-
ium-Iodide dye was detected at FL3 channel (620 nm), and FITC
Annexin V intensity was detected at FL1 channel (525 nm) with a
Cytomic FC 500 flow cytometer (Beckman Coulter, Fullerton, CA, USA).
Defining the quadrants of dead cells (positive for propidium iodide) and
live cells (minimal staining for both Propidium Iodide and FITC Annexin
V) was performed on control samples and identical boundaries were uti-
lized for all samples.
Intracellular ROS detection
Intracellular reactive oxygen species (ROS) levels were measured by flu-
orescence using CM-H2DCFDA (Thermo Fisher Scientific) fluorescence
dye as a ROS probe. SH-SY5Y cells were cultured as mentioned above.
Before the experiments, the cells were lifted from the flasks by 0.25%
trypsin/0.5 mM EDTA/PBS then immediately washed with pre-warmed
complete media to neutralize trypsin. Next, the cells were quickly
washed in Hank’s balanced salt solution (HBSS), and resuspended in
HBSS containing 1% bovine serum albumin, 1.2 mM Ca2+, 1.0 mM
Mg2+ and 2 lM CM-H2DCFDA. Samples were incubated in the dark at
room temperature for 30 min. Cell suspensions were gently mixed
every 10 min. during the incubation to prevent the attachment to the
vessels’ wall. Following two wash steps to remove the excess of the
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fluorescence dye, the cells were resuspended in HBSS. Fluorescence
signal was measured at 25°C by F4500 fluorescence spectrophotometer
(Hitachi High-Technologies Europe, Krefeld, Germany) at excitation
wavelength of 490 nm and emission wavelength of 525 nm. Baseline
level of fluorescence was recorded for ~1 min. before the addition of
0.5 mM H2O2 or vehicle. The relative level of ROS was expressed as F/
F0 values. Fluorescence signal was monitored for 10 min. following per-
oxide or vehicle treatment.
Real-time RT-PCR analysis
Total RNA was isolated from SH-SY5Y neuroblastoma cells using RNeasy
Mini Kit (Qiagen, Hilden, Germany). RNA quantity was determined using a
Nanodrop Implen Nanophotometer. Reverse transcription into cDNA was
performed with iScript cDNA Synthesis Kit (Bio-Rad). Pre-designed Taq-
Man assay (Roche Applied Science) was used to determine mRNA expres-
sion levels of human OGT and glucosamine-fructose-6-phosphate
aminotransferase (GFAT). As a reference gene, human porphobilinogen
deaminase (PBGD) was used. Amplification primers and hydrolysis probes
were designed using ProbeFinder software (www.universalprobelibrary.
com). Sequences of the forward and reverse primers of OGT were
50-AGACGATGGCACAAACTTCC-30 and 50-ATCAGCTGCTTTTCCATTGC-30,
the hydrolysis probe was UPL #29. Sequences of the forward and reverse
primers of GFAT were 50-TGAGATTGGTGTGGCCAGTA-30 and 50-GGCAAA-
CATCACAAGGGATAC-30, the hydrolysis probe was U PL #20. The
sequences of the reference gene PBGD were as follows: sense 50-TGCCA-
GAGAAGAGTGTGGTG-30, antisense 50-AGCCGGGTGTTGAGGTTT-30, the
hydrolysis probe was UPL #24. Real-time PCR was performed in a Light-
Cycler thermal cycler (Roche Applied Science). Each reaction was per-
formed in a 20 ll volume, using the LightCycler Taqman Master Mix
(Roche Applied Science). Both target and reference genes were amplified
with efficiencies near 100% and within 5% of each other. For the relative
gene expression analysis, the 2DDCt (Livak) method was used. The
expression level of the gene of interest was compared with the level of
PBGD in each sample.
Immunofluorescence microscopy
Cells were grown on coverslips and after oxidative stress/recovery
treatments they were washed twice in ice-cold PBS. Next, the cells
were fixed in 10% PBS-buffered formaldehyde for 30 min. at room
temperature, subsequently washed with PBS. To avoid formaldehyde
autofluorescence, the coverslips were quenched with 50 mM ammo-
nium chloride for 10 min. Cells were permeabilized with 0.1% Triton-
X 100 for 5 min. Non-specific sites were blocked with 5% bovine
serum albumin (Sigma-Aldrich) in PBS for 5 min. and then the cov-
erslips were incubated at room temperature with CTD110.6 mono-
clonal antibody for 30 min. at a dilution of 1:100 in 5% BSA/PBS.
After rinsing three times with PBS, the samples were incubated with
Alexa Fluor 594 goat antimouse IgM secondary antibody (1:200;
Thermo Fisher Scientific) for 30 min. in dark. Nuclei were counter-
stained with Hoechst dye at a dilution of 1:5000 for 15 min. at room
temperature. Finally, coverslips were mounted with Vectashield (Vec-
tor Laboratories, Burlingame, CA, USA) mounting medium. Image
acquisition was performed with a Zeiss Axiovert 35 (Carl Zeiss
Microscopy GmbH, Jena, Germany) inverted fluorescent microscope
with CellD (Olympus, Tokyo, Japan) software.
Data analysis
Data are presented as means  S.E.M. throughout. Comparisons were
performed with repeated measures one-way ANOVA and statistically sig-
nificant differences between groups were defined as P < 0.05 and are
indicated in the legends of figures.
Results
Effect of treatment with 0.5 mM H2O2 for 30 min.
on cell survival
We have used H2O2 to expose SH-SY5Y neuroblastoma cells to
oxidative stress. Figure 1A shows that the addition of 0.5 mM H2O2
markedly increased the level of intracellular ROS as measured by
the ROS sensitive fluorescent dye CM-H2DCFDA. To simulate acute
oxidative stress and subsequent recovery, we exposed the cells to
0.5 mM H2O2 for 30 min. and then carefully washed out the oxida-
tive agent from the medium to allow the cells to recover (Fig. 1B).
Intracellular ROS levels were also assessed at various timepoints
(1–6 hrs) after the removal of H2O2 from the media, but no signifi-
cant difference could be found between control and H2O2-treated
cells (data not shown). Next, the cells were incubated under normal
growth conditions for up to 72 hrs. The damage caused by oxida-
tive stress was fully apparent at 24 hrs after the treatment (the ratio
of dead cells increased to 22.6 (7.3) % compared to 6.7 (2.5)
% of the control). The ratio of dead cells did not increase any fur-
ther (22.3 (7.1) % and 15.8 (5.0) % after 48 and 72 hrs,
respectively).
Immunofluorescence microscopy reveals
dynamic changes in protein O-GlcNAcylation
To assess the effect of oxidative stress induced by 30 min. treatment
with 0.5 mM H2O2 on protein O-glycosylation, SH-SY5Y cells were
formalin fixed and labelled with anti-O-GlcNAc monoclonal antibody
(CTD110.6) after exposing them to conditions analogous to the cell
survival experiments. Figure 2 shows control and stress-exposed
cells after various recovery times. Similar to other cell types, SH-
SY5Y cells showed abundant, diffuse granular cytoplasmic CTD110.6
positivity. Whereas each cell seemed to increase its overall O-GlcNAc
levels upon stress, we found some very intensely labelled cells that
also appeared to have more compact and round-shaped morphology.
Based on Hoechst nuclear counterstaining, these cells were either
mitotic cells or apoptotic cells, the latter more frequently appearing in
the late post-stress phase (data not shown). Fluorescence intensity
was averaged for all experimental conditions and is summarized in
the bar graph shown at the right of Figure 2. Although no significant
increase in intensity was observed at 2 hrs compared with control,
we found significant changes within stress-exposed cells as recovery
time progressed.
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Elevation in O-GlcNAc protein and decrease/
reduce in protein phosphorylation
The dynamic changes in O-GlcNAc levels demonstrated by
immunofluorescence were confirmed by immunoblots. We found that
SH-SY5Y cells required about 2–4 hrs to reach peak level of
O-GlcNAc following oxidative stress induced by 30 min. treatment
with 0.5 mM H2O2. On the long run, O-GlcNAc levels returned to nor-
mal intensities after about 24–48 hrs (Fig. 3).
Many studies have shown an interaction between O-GlcNAc and
other signalling mechanisms, the most documented one is the recip-
rocal relationship between O-GlcNAc and phosphorylation, particu-
larly on tau proteins which play a key role in the development of
Alzheimer’s disease [22]. As of today, scientific consensus agrees
that proper O-GlcNAcylation can prevent the hyperphosphorylation of
tau proteins and subsequent formation of neurofibrillary tangles [23].
In this study, we analysed the level of tau phosphorylation (Fig. 3B)
using an antibody against total tau and phophospecific antibody
against tau [Ps199], [Ps262] and PHF1. We found that the ratio of tau
[Ps199] and PHF1 compared with the amount of total tau protein level
significantly decreased after oxidative stress induced by 30 min.
treatment with 0.5 mM H2O2. After 24–72 hrs of recovery times, both
[Ps199] tau and PHF1 phosphorylation returned to baseline levels,
which dynamic seems to be the opposite of the overall O-GlcNAc
levels’ dynamic. On the other hand, [Ps262] phosphorylation seemed
to follow a parallel dynamic to O-GlcNAcylation; short-term elevation
after oxidative stress followed by decreased level of phosphorylation
during the recovery phase.
Real-time PCR analysis of GFAT and OGT mRNA
expression in SH-SY5Y neuronal cell culture
Protein O-GlcNAc modification is regulated by OGT which is the only
enzyme responsible to the addition of the N-acetyl-glucosamine moi-
ety to Ser/Thr residues. However, metabolic flux through the
Fig. 1 Effect of moderate oxidative stress on cell viability. (A) Intracellular ROS levels measured by ROS sensitive fluorescent dye CM-H2DCFDA.
SH-SY5Y cells were treated with either 0.5 mM H2O2 or vehicle (control) starting at 0 sec. and the change in fluorescence signal was recorded for
500 sec. Representative curves of relative fluorescence (F/F0) are shown on the left, whereas the average increase in fluorescence signal 500 sec.
after the start of the experiment is shown on the right. Data are means  S.E.M. from three independent experiments. *P < 0.05 versus control.
(B) SH-SY5Y cells were treated with 0.5 mM H2O2 for 30 min. in serum-free growth medium, then the medium was replaced and cells were incu-
bated under normal growth conditions. The indicated times refer to the recovery time after the end of H2O2 treatment. At those time points, cells
were collected and cell viability assay was performed to measure the percentage of living cells (Annexin V and Propidium-Iodide negative) and dead
cells (Propidium-Iodide positive). Data are means  S.E.M. from eight independent experiments. *P < 0.05 versus control.
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Fig. 2 Immunofluorescence shows temporal dynamic of protein O-
GlcNAc modification after oxidative stress. Immunofluorescence label-
ling was performed on SH-SY5Y cells using the anti-O-GlcNAc antibody
CTD110.6 and Hoechst was used as a nuclear counterstain. Cells were
treated with 0.5 mM H2O2 for 30 min. then replaced in growth medium
to let the cells recover for up to 72 hrs. Left: representative images at
the indicated times after oxidative stress are shown. Right: quantitative
analysis of immunofluorescent recordings. The data are the cumulative
sum from three independent experiments; average pixel intensity was
collected from at least 15 cells and normalized to Hoechst counterstain.
Data are shown as means  S.E.M., *P < 0.05 versus 0 hr.
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hexosamine biosynthesis pathway (HBP) also influences O-GlcNAc
levels by the regulation of the availability of UDP-GlcNAc. The first,
rate-limiting step of HBP is catalysed by GFAT. Therefore, we anal-
ysed the mRNA expressional levels of two key enzymes related to O-
GlcNAc; GFAT (Fig. 4A) and OGT (Fig. 4B).
SH-SY5Y cells were exposed to the same oxidative stress condi-
tion and recovery periods as described above. We found that the
mRNA level of both GFAT and OGT showed a biphasic dynamic. First,
GFAT and OGT mRNA was increased by up to ~39 the normal
expressional rate peaking at 4 hrs post-stress, than the expressional
levels gradually decreased close to the normal levels in the next
3 days.
Discussion
In this study we demonstrated the effect of 30 min. treatment with
0.5 mM H2O2 on the regulation of the O-GlcNAc dynamics in SH-
SY5Y neuroblastoma cells. We have found that following this oxida-
tive stress, protein O-GlcNAc modification and mRNA expressional
levels of GFAT and OGT, the rate-limiting enzymes of HBP and O-
GlcNAc, respectively, are all changing in a very similar manner over
time (Figs 3 and 4). O-GlcNAc levels were increased significantly
reaching peak values 2–4 hrs post-stress. At a longer time scale –
after about 24–72 hrs – the cells apparently recovered from the
stress and O-GlcNAc returned to normal levels similar to what was
observed prior to stress. Interestingly, we found that tau phosphory-
lation changed in a reciprocal way; it decreased at 2–4 hrs after
stress, but increased again after about 72 hrs following stress. These
results suggest that O-GlcNAc modification is a sensitive, dynamic
marker of cellular stress and that its interaction with other intracellu-
lar processes (such as the Alzheimer’s hallmark tau phosphorylation)
can have both acute and chronic consequences.
O-GlcNAc seems to regulate (or at the least influence) many
intracellular processes such as cell-cycle [24], epigenetics [25],
stress adaptation [12], Ca2+ signalling [26] or phosphorylation [27],
consequently its imbalance has been investigated in the development
of many diseases. Since its discovery [28], O-GlcNAc has been
implicated either as a beneficial (e.g. in Alzheimer’s disease [29] and
ischemia reperfusion [30]), or as an adverse factor (insulin resis-
tance, diabetes [22] and malignant disorders [31]). Chronic diseases
in which O-GlcNAc seems to be involved take years or even decades
to develop; however, O-GlcNAc also has relevance in cellular mecha-
nisms that take place at a much shorter time scale. In particular,
stress response and the role of O-GlcNAc in cellular adaptation to
various stresses such as hypoxia or oxidative stress has been inten-
sively studied [32, 33]. Most of these studies were conducted on
cardiomyocytes and on isolated perfused hearts. Overwhelming
number of evidence from these studies suggests two main conclu-
sions; (i) overall O-GlcNAc level tends to increase shortly after
stress, (ii) increasing the level of O-GlcNAc seems to protect from
the deleterious effect of stress [30, 34–36]. Theories have been put
forward to explain the protective effect of O-GlcNAc, such as HSP
activation or modulation of Ca2+ signalling [32, 37], but the complex
pro-survival mechanism of O-GlcNAc remains to be elucidated. In
contrast to cardiac tissue, relatively little is known about O-GlcNAc’s
behaviour during stress in the neuronal tissue. Interestingly, the
available literature suggests that O-GlcNAc is rather down-regulated
by hypotonic [38], or LPS-induced stress [39]. On the other hand
(and paradoxically), Cheung and Hart [40] found that glucose depri-
vation significantly increased O-GlcNAc levels in Neuro-2a murine
neuroblastoma cells. In our present experiments we have found that
in SH-SY5Y cell line, which is a human neuroblastoma cell line, O-
GlcNAc levels behave in a similar manner as in cardiomyocytes
(Fig. 3). Moreover, O-GlcNAc elevation was accompanied by the up-
regulation of key regulators of the HBP pathway, to support the cells’
need for more O-GlcNAc (Fig. 4). Thus, our data demonstrate that
O-GlcNAc increases upon oxidative stress are an actively regulated
process in neuronal cells.
Contrary to the relatively unexplored behaviour of O-GlcNAc dur-
ing acute stress response in neuronal cells, its reciprocal relationship
with phosphorylation and imbalance in Alzheimer’s disease is well-
established [19, 22]. According to the generally accepted view, the
dynamic balance between phosphorylation and O-GlcNAc modifica-
tion on tau proteins in Alzheimer’s patients is shifted in favour of the
phosphorylation which will result in hyperphosphorylated tau and
neurofibrillary tangle deposition. Stress, and especially oxidative
stress is also strongly implicated in the pathophysiology of Alzhei-
mer’s disease, however, the exact relationship between oxidative
stress and tau phosphorylation is controversial. Some of the oxidative
agents cause hyperphosphorylation, whereas others induce de-phos-
phorylation of tau [41]. Multiple studies also indicated that tau hyper-
phosphorylation can follow, but also precede oxidative stress [42]. To
our knowledge, O-GlcNAc modification of tau has not been investi-
gated in oxidative stress before, however, common sense dictates
that the reciprocal relationship between phosphorylation and
O-GlcNAc should be maintained also under this condition. In our
experiments, we have found that 30 min. long oxidative stress by
H2O2 resulted in temporal decrease of tau phosphorylation at site
S199 and PHF1, but reciprocal elevation in O-GlcNAc modified pro-
teins (Fig. 3). Interestingly, the phosphorylation at site S262 showed
similar dynamic pattern as O-GlcNAc levels. Although the interplay
between O-GlcNAc and phosphorylation is usually characterized by
same site competition, other mechanism such as proximal site
Fig. 3 Temporal dynamics of O-GlcNAc modification and tau phosphorylation after oxidative stress revealed by Western blot. (A) Western blot analy-
sis using SYPRO Ruby Blot Total Protein Staining and CTD110.6 antibody and (B) actin, total tau, [Ps199], [Ps262] and PHF1 staining shows repre-
sentative samples of protein extracts from SH-SY5Y cells previously incubated for 30 min. with 0.5 mM H2O2 then replaced in normal growth
medium to recover. (C) Densitometric analysis of the CTD110.6 and [Ps199], [Ps262] and PHF1 staining over time. Levels are expressed as a per-
centage of the baseline ratio. Each data point represents the average of at least three separate experiments. Data are shown as means  S.E.M.,
*P < 0.05 versus Control, #P < 0.05 versus 2 hrs.
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competition or proximal site occupation is also known [13]. Increased
phosphorylation at S262 (and possibly at other sites as well) after
oxidative stress despite elevated level of O-GlcNAc could be the result
that either O-GlcNAc is not competing or even contributing to phos-
phorylation under various conditions.
Although our O-GlcNAc data collected from SH-SY5Y neuroblas-
toma exposed to H2O2 induced oxidative stress are in accordance
with the data found in cardiomyocytes and also demonstrate the
reciprocal relationship between O-GlcNAc and specific tau phosphory-
lation sites, the question whether these effects observed at short term
could be understood and interpreted also under chronic conditions
remains to be answered. In Alzheimer’s disease, despite oxidative
stress is a major factor in the pathophysiology, the dynamic of
O-GlcNAc seems to be reversed. It is also important to note that dia-
betes is a risk factor for Alzheimer’s disease [43]. One of the mecha-
nism by which diabetes could accelerate the development of AD is
increased ROS production. Insulin resistance in type 2 diabetes was
also found to be associated with AD. How big of a role O-GlcNAc
plays in these processes and how these processes are related to the
regulation of tau phosphorylation still needs to be addressed. Never-
theless, we think that studying O-GlcNAc modification simultaneously
with tau phoshorylation in oxidative stress-exposed neuronal cells
should significantly contribute to the understanding of the develop-
ment of Alzheimer’s disease.
A number of studies deal with the role of O-GlcNAc in various
stress situations [12, 13, 32, 33]. Here, we demonstrated, for the first
time, that treatment with 0.5 mM H2O2 for 30 min. to induce oxida-
tive stress causes a rapid, temporary increase in O-GlcNAc in SH-
SY5Y neuroblastoma cells. We have also shown that the dynamic
changes in protein O-GlcNAc modification can behave in an inverse
relationship with tau phosphorylation during recovery from oxidative
stress. Taken together, we think that O-GlcNAc regulation is an
important mechanism in stress adaptation and it is conceivable that
protein O-GlcNAc modification is part of a complex system that influ-
ences not only short-term effects but also chronic pathophysiologic
events such as Alzheimer’s disease.
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